Rauvolfia afra
Rauvolfia afra · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Rauvolfia afra is a medicinal shrub widely recognized for its significant pharmacological potential in traditional healing practices. Recent scientific investigations have focused on its unique chemical profile, specifically highlighting the presence of PPS. Researchers are increasingly interested in how these specific compounds interact with biological systems to provide therapeutic benefits. One promising area of study involves the development of specialized preparations using pectic polysaccharides to enhance delivery. Understanding these complex interactions is essential for unlocking the full medicinal value of this versatile plant.
- Synonyms
- Rauvolfia Afra Var. Natalensis · Rauvolfia Goetzei · 9 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Rauvolfia afra is a versatile plant known by several distinct names across different regions. It is frequently referred to as African-quinine due to its significant medicinal properties. Depending on the local dialect or area, you may also encounter it called Kinaboom or Kinaboon. In other communities, the species is recognized by the names Munadzi and Musingwisi. These varied common names highlight the plant's deep-rooted cultural and botanical significance.
Sources: Catalogue of Life (COL)
Synonyms
Rauvolfia afra is a taxonomically complex species that is frequently associated with several different botanical synonyms. Within various scientific records, it is often identified under the name Rauvolfia afra var. natalensis. The plant is also linked to Rauvolfia goetzei and Rauvolfia gonioclada in many botanical studies. Furthermore, researchers frequently encounter it listed as Rauvolfia inebrians or Rauvolfia mayombensis. Understanding these overlapping classifications is essential for accurately identifying the plant in diverse ecological contexts.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Rauvolfia afra is a distinctive member of the kingdom Plantae. Within this vast botanical realm, the species belongs to the class Equisetopsida. It is further categorized under the order Gentianales, showcasing its specific evolutionary lineage. This plant is a primary representative of the genus Rauvolfia. Finally, it is classified within the family Apocynaceae, completing its scientific identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Rauvolfia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Rauvolfia afra is a plant species with a significant presence across the African continent. It is widely distributed throughout East Tropical Africa, where it can be found in Kenya, Tanzania, and Uganda. The species also extends its reach into Northeast Tropical Africa, establishing itself in regions such as Chad. Furthermore, its range continues through the territory of Sudan and South Sudan. This broad distribution highlights the plant's adaptability to various tropical environments within the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Rauvolfia afra is a plant of significant medicinal interest, particularly regarding its potential to treat inflammatory conditions. Research indicates that pectic polysaccharides (PPs) can be extracted from the Rauvolfia genus to provide therapeutic benefits. Specifically, these pectic polysaccharides have been shown to inhibit the progression of colon ulcers in experimental models. The study highlights that the administration of PPs helps to ameliorate the pathology of ulcerative colitis in mice. Most notably, these polysaccharides exert their protective effect by effectively reducing the process of pyroptosis.
Conditions
Preparations
Rauvolfia afra is prepared as pectic polysaccharides to investigate their therapeutic potential in treating inflammatory conditions. These extracted pectic polysaccharides serve as a primary subject of study for their ability to inhibit the progression of colon ulcers. Research specifically focuses on how these substances can ameliorate the pathology of ulcerative colitis in murine models. By administering these prepared polysaccharides, scientists observed a reduction in pyroptosis within the colon tissues. Ultimately, the preparation of pectic polysaccharides from the Rauvolfia genus provides a mechanism to attenuate experimental damage caused by colitis.